Testing effectiveness (Phase 2)Looking for participantsNCT05017545
What this trial is testing
Carfilzomib and Belatacept for Desensitization
Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 15